EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

siRNA Therapeutics for the Treatment of Hereditary Diseases and Other Conditions: A Review

Alexei Shevelev, Natalia Pozdniakova iD, Evgenii Generalov iD, Olga Tarasova iD

International Journal of Molecular Sciences · 05.09.2025 · 26 (17) · 8651

DOI: 10.3390/ijms26178651 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 05.09.2025. Verfasst von Alexei Shevelev und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of DNA metylom and transcriptom editing, Vavilov Institute of General Genetics of Russian Academy of Sciences, Gubkina 3, 119991 Moscow, R…. Hauptthemen laut MEDLINE: RNA, Small Interfering, Genetic Diseases, Inborn, RNAi Therapeutics, Amyloid Neuropathies, Familial. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Program for Basic Research in the Russian Federation for a long-term period (2021-2030).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

RNA-based drugs hold significant potential, offering promising new treatments for a wide range of diseases, especially those with a genetic basis. By leveraging RNA interference (RNAi) and other RNA-mediated mechanisms, these therapies can precisely modulate gene expression and address the root causes of genetic defects. RNA-based drugs hold significant potential for treating a range of diseases. However, the transition of these therapies from laboratory research to clinical applications has encountered hurdles. This review explores the composition and outcomes of clinical trials for various modified short RNA drugs. We detail their mechanisms of action, delivery systems—with a focus on lipid nanoparticles and N-acetylgalactosamine (GalNAc) conjugates—and clinical efficacy in treating conditions such as transthyretin (TTR) amyloidosis. Our analysis reveals that while several RNAi-based drugs have achieved clinical approval, a critical unmet need remains: advanced delivery systems capable of precisely targeting diverse tissues, particularly outside the liver. We also underscore the importance of rigorous target validation utilising sophisticated bioinformatics tools and in vitro/in vivo assays to minimise off-target effects and ensure robust therapeutic efficacy. This review proposes a novel framework for optimising RNA drug development, emphasising the crucial interplay between delivery strategies, target specificity, and understanding disease-specific target biology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, Small InterferingGenetic Diseases, InbornRNAi TherapeuticsAmyloid Neuropathies, FamilialHumansAnimalsNanoparticlesRNA InterferenceGenetic Therapy

Stichwörter der Autor:innen

GalNAc conjugatesLNPsRNA interferenceRNA therapygene therapysiRNA

Substanzen

RNA, Small Interfering

Autor:innen und Institutionen

  • Laboratory of DNA metylom and transcriptom editing, Vavilov Institute of General Genetics of Russian Academy of Sciences, Gubkina 3, 119991 Moscow, Russia.
  • Laboratory of radionuclide and radiation technologies in experimental oncology, Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian Federation, Kashirskoe Shosse 24, 115522 Moscow, Ru…
  • Department of Biophysics, Faculty of Physics, Lomonosov Moscow State University, 119991 Moscow, Russia.
  • Laboratory of Big Data Analysis for Digital Pharmacology, Department of Bioinformatics, Institute of Biomedical Chemistry of Russian Academy of Sciences, Pogodinskaya 10, 8, 119121 Moscow, Russia.

ORCID-Profile: Natalia Pozdniakova, Evgenii Generalov, Olga Tarasova

Förderung

  • Program for Basic Research in the Russian Federation for a long-term period (2021-2030)

Zitieren

APA

Shevelev, A., Pozdniakova, N., Generalov, E., & Tarasova, O. (2025). siRNA Therapeutics for the Treatment of Hereditary Diseases and Other Conditions: A Review. International Journal of Molecular Sciences, 26(17), 8651. https://doi.org/10.3390/ijms26178651

Vancouver

Shevelev A, Pozdniakova N, Generalov E, Tarasova O. siRNA Therapeutics for the Treatment of Hereditary Diseases and Other Conditions: A Review. International Journal of Molecular Sciences. 2025;26(17):8651. doi:10.3390/ijms26178651

BibTeX
@article{Shevelev2025,
  author = {Shevelev, Alexei and Pozdniakova, Natalia and Generalov, Evgenii and Tarasova, Olga},
  title = {siRNA Therapeutics for the Treatment of Hereditary Diseases and Other Conditions: A Review},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {17},
  pages = {8651},
  doi = {10.3390/ijms26178651}
}
Kostenlos starten →